DBV Technologies (DBVT) News Today $4.47 -0.26 (-5.50%) As of 01/17/2025 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period DBV Technologies (NASDAQ:DBVT) Coverage Initiated by Analysts at StockNews.comStockNews.com assumed coverage on shares of DBV Technologies in a research note on Friday. They set a "hold" rating on the stock.January 17 at 2:07 AM | marketbeat.comHalf-Year Report on the DBV Technologies Liquidity Contract with ODDO BHFJanuary 13, 2025 | globenewswire.comJMP Securities Reiterates "Market Outperform" Rating for DBV Technologies (NASDAQ:DBVT)January 12, 2025 | americanbankingnews.comDBV Technologies' (DBVT) "Market Outperform" Rating Reaffirmed at JMP SecuritiesJMP Securities reissued a "market outperform" rating and set a $10.00 price target on shares of DBV Technologies in a report on Friday.January 10, 2025 | marketbeat.comPositive Outlook on Viaskin Peanut Treatment Drives Buy Rating for DBV TechnologiesJanuary 10, 2025 | markets.businessinsider.comDBV Technologies (NASDAQ: DBVT) Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension StudyJanuary 10, 2025 | americanbankingnews.comStockNews.com Begins Coverage on DBV Technologies (NASDAQ:DBVT)January 9, 2025 | americanbankingnews.comStockNews.com Initiates Coverage on DBV Technologies (NASDAQ:DBVT)StockNews.com initiated coverage on DBV Technologies in a research note on Thursday. They set a "hold" rating on the stock.January 9, 2025 | marketbeat.comDBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension StudyJanuary 8, 2025 | markets.businessinsider.comDBV Technologies (NASDAQ:DBVT) Shares Pass Below Fifty Day Moving Average - Should You Sell?DBV Technologies (NASDAQ:DBVT) Stock Price Crosses Below Fifty Day Moving Average - Time to Sell?January 1, 2025 | marketbeat.comDBV Technologies (NASDAQ:DBVT) Coverage Initiated at StockNews.comStockNews.com initiated coverage on DBV Technologies in a research report on Wednesday. They set a "hold" rating on the stock.January 1, 2025 | marketbeat.comDBV Technologies (NASDAQ:DBVT) Now Covered by Analysts at StockNews.comStockNews.com began coverage on DBV Technologies in a report on Tuesday. They issued a "hold" rating for the company.December 24, 2024 | marketbeat.comDBV Technologies Amends Executive Severance AgreementsDecember 20, 2024 | markets.businessinsider.comDBV Technologies Aligns with FDA for Viaskin Peanut ApprovalDecember 13, 2024 | markets.businessinsider.comDBV jumps 52% to $4.99 after aligning with FDA on approval pathwayDecember 12, 2024 | markets.businessinsider.comDBV Technologies announces FDA alignment on Viaskin Peanut patch program pathwayDecember 12, 2024 | markets.businessinsider.comStocks to Watch: Adobe, Champions Oncology, DBV TechnologiesDecember 11, 2024 | marketwatch.comDBV Shares Rise 31%, Confirms Alignment With FDA on Accelerated Approval for Peanut PatchDecember 11, 2024 | marketwatch.comDBV stock rallies post-market on FDA Viaskin updateDecember 11, 2024 | seekingalpha.comDBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-OldDecember 11, 2024 | globenewswire.comDBV Technologies price target raised to $10 from $5 at JMP SecuritiesDecember 6, 2024 | markets.businessinsider.comDBV Technologies S.A. (NASDAQ:DBVT) Short Interest Down 5.3% in NovemberDBV Technologies S.A. (NASDAQ:DBVT - Get Free Report) was the recipient of a large decline in short interest in the month of November. As of November 15th, there was short interest totalling 1,260,000 shares, a decline of 5.3% from the October 31st total of 1,330,000 shares. Based on an average trading volume of 671,600 shares, the short-interest ratio is currently 1.9 days. Approximately 1.3% of the shares of the company are sold short.December 3, 2024 | marketbeat.comEleven option delistings on November 18thNovember 18, 2024 | markets.businessinsider.comDBV Technologies announces ADS ratio changeNovember 13, 2024 | markets.businessinsider.comDBV Technologies Stock to Reverse Split on Friday, November 29th (NASDAQ:DBVT)DBV Technologies S.A. (NASDAQ:DBVT - Free Report)'s stock is set to reverse split on the morning of Friday, November 29th. The 1-5 reverse split was announced on Monday, November 11th. The number of shares owned by shareholders will be adjusted after the market closes on Thursday, November 28th.November 13, 2024 | marketbeat.comDBV Technologies Announces Plan to Implement ADS Ratio ChangeNovember 11, 2024 | globenewswire.comDBV Technologies Reports Third Quarter 2024 Financial ResultsNovember 6, 2024 | globenewswire.comDBV Technologies (NASDAQ:DBVT) Stock Passes Above Fifty Day Moving Average - Here's WhyDBV Technologies (NASDAQ:DBVT) Stock Price Passes Above Fifty Day Moving Average - Here's WhyNovember 6, 2024 | marketbeat.comDBV Technologies (NASDAQ:DBVT) Research Coverage Started at StockNews.comStockNews.com began coverage on shares of DBV Technologies in a report on Tuesday. They set a "hold" rating for the company.October 29, 2024 | marketbeat.comDBV Technologies rating suspended at Goldman SachsOctober 25, 2024 | markets.businessinsider.comHC Wainwright Has Positive Estimate for DBVT FY2024 EarningsDBV Technologies S.A. (NASDAQ:DBVT - Free Report) - Research analysts at HC Wainwright increased their FY2024 earnings per share estimates for DBV Technologies in a report issued on Wednesday, October 23rd. HC Wainwright analyst A. Fein now anticipates that the company will post earnings per sharOctober 25, 2024 | marketbeat.comDBV Technologies (NASDAQ:DBVT) Price Target Increased to $7.00 by Analysts at HC WainwrightHC Wainwright increased their price objective on DBV Technologies from $5.00 to $7.00 and gave the company a "buy" rating in a research report on Thursday.October 24, 2024 | marketbeat.comFrench Biotech Stock Soars On Regulatory UpdatesOctober 24, 2024 | msn.comDBV Technologies price target raised to $7 from $5 at H.C. WainwrightOctober 24, 2024 | markets.businessinsider.comDBV Tech spikes after regulatory update on lead assetOctober 24, 2024 | seekingalpha.comPenny Stock DBV Technologies Advances Viaskin Peanut Allergy Patch With FDA Approval PathwayOctober 24, 2024 | msn.comDBV Technologies Rally 47% Following Positive Updates for Peanut Allergy PatchOctober 22, 2024 | marketwatch.comDBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and EuropeOctober 22, 2024 | globenewswire.comDBV Technologies to Participate in Upcoming ACAAI 2024 CongressOctober 18, 2024 | globenewswire.comDBV Technologies SA (DBVT) (Q2 2024) Earnings Call Highlights: Strategic Advances Amid ...October 9, 2024 | finance.yahoo.comDBV Technologies (NASDAQ:DBVT) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comPoint72 Asset Management L.P. Has $1.25 Million Stock Holdings in DBV Technologies S.A. (NASDAQ:DBVT)Point72 Asset Management L.P. lessened its position in DBV Technologies S.A. (NASDAQ:DBVT - Free Report) by 50.0% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,556,250 shares of the company's stock after selling 1,556,250 shares durOctober 4, 2024 | marketbeat.comDBV Technologies Completes Screening for the VITESSE Phase 3 Clinical TrialSeptember 23, 2024 | globenewswire.comShort Interest in DBV Technologies S.A. (NASDAQ:DBVT) Declines By 5.1%DBV Technologies S.A. (NASDAQ:DBVT - Get Free Report) was the target of a large decrease in short interest in the month of August. As of August 31st, there was short interest totalling 278,800 shares, a decrease of 5.1% from the August 15th total of 293,700 shares. Based on an average daily trading volume, of 50,900 shares, the short-interest ratio is presently 5.5 days. Approximately 0.3% of the company's shares are sold short.September 18, 2024 | marketbeat.comDBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | globenewswire.comDBV Technologies (NASDAQ:DBVT) Stock Price Crosses Below 50-Day Moving Average of $0.89DBV Technologies (NASDAQ:DBVT) Stock Price Passes Below 50-Day Moving Average of $0.89September 3, 2024 | marketbeat.comDBV Technologies S.A. (NASDAQ:DBVT) Sees Large Increase in Short InterestDBV Technologies S.A. (NASDAQ:DBVT - Get Free Report) was the target of a significant growth in short interest in July. As of July 31st, there was short interest totalling 307,100 shares, a growth of 6.3% from the July 15th total of 288,800 shares. Currently, 0.3% of the company's stock are short sold. Based on an average trading volume of 94,100 shares, the short-interest ratio is currently 3.3 days.August 18, 2024 | marketbeat.comDBV Technologies (NASDAQ:DBVT) Now Covered by StockNews.comStockNews.com started coverage on DBV Technologies in a research report on Saturday. They set a "hold" rating on the stock.August 10, 2024 | marketbeat.comHC Wainwright Reaffirms Buy Rating for DBV Technologies (NASDAQ:DBVT)HC Wainwright restated a "buy" rating and set a $5.00 price target on shares of DBV Technologies in a research report on Thursday.August 1, 2024 | marketbeat.comDBV Technologies (NASDAQ:DBVT) Price Target Raised to $5.00JMP Securities increased their price objective on DBV Technologies from $4.00 to $5.00 and gave the company a "market outperform" rating in a research report on Wednesday.July 31, 2024 | marketbeat.com Get DBV Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for DBVT and its competitors with MarketBeat's FREE daily newsletter. Email Address DBVT Media Mentions By Week DBVT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DBVT News Sentiment▼0.740.46▲Average Medical News Sentiment DBVT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DBVT Articles This Week▼42▲DBVT Articles Average Week Get DBV Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for DBVT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ABIVAX Société Anonyme News PureTech Health News Kamada News Cryoport News Astria Therapeutics News Allogene Therapeutics News Akebia Therapeutics News ChromaDex News Terns Pharmaceuticals News Kodiak Sciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DBVT) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DBV Technologies S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share DBV Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DBVT Stock Alerts